{"id": "article-22692_0", "title": "Hemangioma -- Continuing Education Activity", "content": "Hemangiomas, colloquially termed \"strawberry marks\", are the most common benign tumor of infancy and are caused by endothelial cell proliferation. Congenital hemangiomas are visible at birth whereas infantile hemangiomas appear later. This activity describes the evaluation and management of hemangiomas and highlights the role of the interprofessional team in caring for patients with hemangiomas.", "contents": "Hemangioma -- Continuing Education Activity. Hemangiomas, colloquially termed \"strawberry marks\", are the most common benign tumor of infancy and are caused by endothelial cell proliferation. Congenital hemangiomas are visible at birth whereas infantile hemangiomas appear later. This activity describes the evaluation and management of hemangiomas and highlights the role of the interprofessional team in caring for patients with hemangiomas."}
{"id": "article-22692_1", "title": "Hemangioma -- Continuing Education Activity", "content": "Objectives: Describe the epidemiology of hemangiomas. Describe the histopathology of hemangiomas. Explain when hemangiomas should be considered on a differential diagnosis. Summarize the treatments of hemangiomas. Access free multiple choice questions on this topic.", "contents": "Hemangioma -- Continuing Education Activity. Objectives: Describe the epidemiology of hemangiomas. Describe the histopathology of hemangiomas. Explain when hemangiomas should be considered on a differential diagnosis. Summarize the treatments of hemangiomas. Access free multiple choice questions on this topic."}
{"id": "article-22692_2", "title": "Hemangioma -- Introduction", "content": "Hemangiomas, also known as hemangiomas of infancy or infantile hemangiomas (IH), are the most common benign tumor of infancy [1] . They are\u00a0often called \"strawberry marks\" due to their clinical appearance. Endothelial cell proliferation results in hemangiomas. There are different types of hemangiomas. Congenital hemangiomas are visible at birth whereas infantile hemangiomas appear later in infancy. Infantile angiomas are characterized by early, rapid growth followed by spontaneous involution.", "contents": "Hemangioma -- Introduction. Hemangiomas, also known as hemangiomas of infancy or infantile hemangiomas (IH), are the most common benign tumor of infancy [1] . They are\u00a0often called \"strawberry marks\" due to their clinical appearance. Endothelial cell proliferation results in hemangiomas. There are different types of hemangiomas. Congenital hemangiomas are visible at birth whereas infantile hemangiomas appear later in infancy. Infantile angiomas are characterized by early, rapid growth followed by spontaneous involution."}
{"id": "article-22692_3", "title": "Hemangioma -- Etiology", "content": "The etiology of infantile hemangiomas is poorly understood, but there are several hypotheses. The most likely hypothesis\u00a0suggests that hypoxic stress upregulates expression of GLUT 1 and VEGF leading to the mobilization of endothelial progenitor cells. The progenitor cells are positive for CD133\u00a0and CD31 [2] .\u00a0Another hypothesis suggests\u00a0that placental trophoblasts serve as the origin of stem cells for hemangiomas [3] . A third hypothesis suggests that\u00a0IH development involves vasculogenesis from progenitor cells (de novo formation) as well as the formation of new vessels from existing ones (angiogenesis) [2] .\u00a0Angiogenic factors have been suggested to act on endothelial cells and pericytes to initiate the formation of a capillary network [4] .", "contents": "Hemangioma -- Etiology. The etiology of infantile hemangiomas is poorly understood, but there are several hypotheses. The most likely hypothesis\u00a0suggests that hypoxic stress upregulates expression of GLUT 1 and VEGF leading to the mobilization of endothelial progenitor cells. The progenitor cells are positive for CD133\u00a0and CD31 [2] .\u00a0Another hypothesis suggests\u00a0that placental trophoblasts serve as the origin of stem cells for hemangiomas [3] . A third hypothesis suggests that\u00a0IH development involves vasculogenesis from progenitor cells (de novo formation) as well as the formation of new vessels from existing ones (angiogenesis) [2] .\u00a0Angiogenic factors have been suggested to act on endothelial cells and pericytes to initiate the formation of a capillary network [4] ."}
{"id": "article-22692_4", "title": "Hemangioma -- Epidemiology", "content": "Infantile hemangioma\u00a0is the most\u00a0common benign vascular tumor of infancy and affects about 4% to 5 % of newborns [5] .\u00a0It is due to an\u00a0abnormal cluster of small blood vessels\u00a0that occurs during the first year of life. Infantile hemangiomas occur more frequently in Caucasian infants compared to other racial groups. There is also a female predominance with a female to male ratio of up to 5:1. Premature infants, babies born with low birth weights or with\u00a0prenatal hypoxia\u00a0are also prone to developing hemangiomas.\u00a0Infantile hemangiomas are common in infants with elder mothers. The disorder is often seen after post chorionic villus sampling or\u00a0in multiple births with twins or triplets. Most cases are sporadic but\u00a0infantile hemangiomas have been seen to run in families. They have been associated with an\u00a0autosomal dominant pattern of inheritance [6] although no specific genes are implicated. [7]", "contents": "Hemangioma -- Epidemiology. Infantile hemangioma\u00a0is the most\u00a0common benign vascular tumor of infancy and affects about 4% to 5 % of newborns [5] .\u00a0It is due to an\u00a0abnormal cluster of small blood vessels\u00a0that occurs during the first year of life. Infantile hemangiomas occur more frequently in Caucasian infants compared to other racial groups. There is also a female predominance with a female to male ratio of up to 5:1. Premature infants, babies born with low birth weights or with\u00a0prenatal hypoxia\u00a0are also prone to developing hemangiomas.\u00a0Infantile hemangiomas are common in infants with elder mothers. The disorder is often seen after post chorionic villus sampling or\u00a0in multiple births with twins or triplets. Most cases are sporadic but\u00a0infantile hemangiomas have been seen to run in families. They have been associated with an\u00a0autosomal dominant pattern of inheritance [6] although no specific genes are implicated. [7]"}
{"id": "article-22692_5", "title": "Hemangioma -- Histopathology", "content": "Upon histopathological examination of an infantile hemangioma, a multinodular pattern fed by a single arteriole can be seen [8] .\u00a0The nodules are composed of hyperplastic endothelial cells, pericytes with\u00a0and without lumens and prominent basement membranes. The involution stage of the hemangioma is marked by dilated vascular lumens and flattened endothelial cells (which give the IH its lobular architecture). Fibrosis becomes pronounced as involution progresses [9] . During involution, IH expresses a tissue inhibitor of metalloproteinase, which also inhibits angiogenesis [4] .\u00a0Placenta-associated vascular antigens staining, including FcRII, Lewis Y antigen (LeY) and merosin, is also observed during involution. Upon immunohistochemical evaluation of the endothelial cells, they express CD31, von Willebrand factor, and urokinase in all phases. Infantile hemangiomas express glucose transporter protein-1 (GLUT 1) during all phases of their development. Thus, immunohistochemical studies\u00a0can be used to distinguish the development\u00a0stages of IH.", "contents": "Hemangioma -- Histopathology. Upon histopathological examination of an infantile hemangioma, a multinodular pattern fed by a single arteriole can be seen [8] .\u00a0The nodules are composed of hyperplastic endothelial cells, pericytes with\u00a0and without lumens and prominent basement membranes. The involution stage of the hemangioma is marked by dilated vascular lumens and flattened endothelial cells (which give the IH its lobular architecture). Fibrosis becomes pronounced as involution progresses [9] . During involution, IH expresses a tissue inhibitor of metalloproteinase, which also inhibits angiogenesis [4] .\u00a0Placenta-associated vascular antigens staining, including FcRII, Lewis Y antigen (LeY) and merosin, is also observed during involution. Upon immunohistochemical evaluation of the endothelial cells, they express CD31, von Willebrand factor, and urokinase in all phases. Infantile hemangiomas express glucose transporter protein-1 (GLUT 1) during all phases of their development. Thus, immunohistochemical studies\u00a0can be used to distinguish the development\u00a0stages of IH."}
{"id": "article-22692_6", "title": "Hemangioma -- History and Physical", "content": "Infantile hemangioma is usually absent at birth but can present with several types of precursor\u00a0lesions. These include a pale area of vasoconstriction, an erythematous macule, a telangiectatic red macule or blue bruise-like patches.\u00a0Infantile hemangiomas\u00a0become clinically apparent within 1 to 4 weeks. The localization is ubiquitous, and they may occur on the skin and mucosal surfaces. The majority present as a single localized cutaneous hemangioma but infantile hemangioma\u00a0may be multifocal or segmental. Hemangiomas occur most commonly on the head and the neck and are seen in 60 % of cases.\u00a0This is followed by lesions on the trunk in 25% of cases, and least commonly, on the extremities, seen in 15% of cases [6] .\u00a0Hemangiomas can be superficial, deep or mixed with\u00a0components\u00a0of both superficial and deep layers. Superficial lesions involve the superficial dermis and are raised, lobulated and bright red. Deep hemangiomas, also called subcutaneous hemangiomas, arise from the reticular dermis and/or the subcutis layer, and appear as a bluish-hued nodule, plaque or tumor. Mixed hemangiomas have features of both locations.", "contents": "Hemangioma -- History and Physical. Infantile hemangioma is usually absent at birth but can present with several types of precursor\u00a0lesions. These include a pale area of vasoconstriction, an erythematous macule, a telangiectatic red macule or blue bruise-like patches.\u00a0Infantile hemangiomas\u00a0become clinically apparent within 1 to 4 weeks. The localization is ubiquitous, and they may occur on the skin and mucosal surfaces. The majority present as a single localized cutaneous hemangioma but infantile hemangioma\u00a0may be multifocal or segmental. Hemangiomas occur most commonly on the head and the neck and are seen in 60 % of cases.\u00a0This is followed by lesions on the trunk in 25% of cases, and least commonly, on the extremities, seen in 15% of cases [6] .\u00a0Hemangiomas can be superficial, deep or mixed with\u00a0components\u00a0of both superficial and deep layers. Superficial lesions involve the superficial dermis and are raised, lobulated and bright red. Deep hemangiomas, also called subcutaneous hemangiomas, arise from the reticular dermis and/or the subcutis layer, and appear as a bluish-hued nodule, plaque or tumor. Mixed hemangiomas have features of both locations."}
{"id": "article-22692_7", "title": "Hemangioma -- History and Physical", "content": "The natural history of infantile hemangioma\u00a0has\u00a0a triphasic evolution: Early proliferative or growth phase: Usually, there is rapid growth during the first three months and gradual growth in months five to eight\u00a0of life. Deep infantile hemangiomas\u00a0tend to proliferate for a longer period and can be seen doing so until the ninth or\u00a0twelfth month of life [3] . Plateau phase: The lesion remains stable and quiescent for a period of months (between 6 and\u00a012 months of life). Involution phase: This may occur within the first year of life and can continue for several years. The regressive infantile hemangiomas\u00a0become softer and more compressible, and the color changes from bright red to purple or gray. The skin may return to normal, but often there are residual changes (excessive fibrofatty tissue, telangiectasia, skin laxity) [3] [7] .", "contents": "Hemangioma -- History and Physical. The natural history of infantile hemangioma\u00a0has\u00a0a triphasic evolution: Early proliferative or growth phase: Usually, there is rapid growth during the first three months and gradual growth in months five to eight\u00a0of life. Deep infantile hemangiomas\u00a0tend to proliferate for a longer period and can be seen doing so until the ninth or\u00a0twelfth month of life [3] . Plateau phase: The lesion remains stable and quiescent for a period of months (between 6 and\u00a012 months of life). Involution phase: This may occur within the first year of life and can continue for several years. The regressive infantile hemangiomas\u00a0become softer and more compressible, and the color changes from bright red to purple or gray. The skin may return to normal, but often there are residual changes (excessive fibrofatty tissue, telangiectasia, skin laxity) [3] [7] ."}
{"id": "article-22692_8", "title": "Hemangioma -- Evaluation", "content": "Most\u00a0Infantile hemangiomas\u00a0are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors.", "contents": "Hemangioma -- Evaluation. Most\u00a0Infantile hemangiomas\u00a0are diagnosed clinically. A skin biopsy can be performed if there is any doubt. Infantile hemangiomas stain positive for GLUT 1. Imaging studies like ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are indicated to confirm the diagnosis and the extent of deep IH without superficial changes. This is done to rule out associated anomalies and to differentiate proliferating IH from other tumors."}
{"id": "article-22692_9", "title": "Hemangioma -- Treatment / Management", "content": "Most infantile hemangiomas\u00a0do not require treatment because they\u00a0resolve on their own. Complicated infantile hemangiomas requires treatment. Recently, beta blockers\u00a0such as oral propranolol (2mg/kg/day) have been shown to be effective as first line therapy. However, the side effect profile of propanolol includes bradycardia, hypotension, bronchospasm, and hypoglycemia. Oral prednisone (2-4mg/kg/day) is an alternative therapy that can be used. The high dose\u00a0of prednisone would have to be\u00a0slowly tapered over weeks to months. Prednisone's adverse reactions\u00a0would include irritability, sleep disturbance, hypertension, bone demineralization, cardiomyopathy, and growth retardation. The topical beta blocker, timolol, is used for smaller,superficial, and uncomplicated, infantile hemangiomas.", "contents": "Hemangioma -- Treatment / Management. Most infantile hemangiomas\u00a0do not require treatment because they\u00a0resolve on their own. Complicated infantile hemangiomas requires treatment. Recently, beta blockers\u00a0such as oral propranolol (2mg/kg/day) have been shown to be effective as first line therapy. However, the side effect profile of propanolol includes bradycardia, hypotension, bronchospasm, and hypoglycemia. Oral prednisone (2-4mg/kg/day) is an alternative therapy that can be used. The high dose\u00a0of prednisone would have to be\u00a0slowly tapered over weeks to months. Prednisone's adverse reactions\u00a0would include irritability, sleep disturbance, hypertension, bone demineralization, cardiomyopathy, and growth retardation. The topical beta blocker, timolol, is used for smaller,superficial, and uncomplicated, infantile hemangiomas."}
{"id": "article-22692_10", "title": "Hemangioma -- Treatment / Management", "content": "Intralesional and topical corticosteroids can be used to treat small focal lesions [3] .\u00a0Otherwise, surgical excision may be considered to prevent complications.\u00a0Surgical excision involves\u00a0removing the residual fibrofatty tissue\u00a0and this improves treatment outcomes. Pulsed dye laser (PDL) is indicated for telangiectasia, but PDL remains controversial for infantile hemangiomas that are deep [10] .", "contents": "Hemangioma -- Treatment / Management. Intralesional and topical corticosteroids can be used to treat small focal lesions [3] .\u00a0Otherwise, surgical excision may be considered to prevent complications.\u00a0Surgical excision involves\u00a0removing the residual fibrofatty tissue\u00a0and this improves treatment outcomes. Pulsed dye laser (PDL) is indicated for telangiectasia, but PDL remains controversial for infantile hemangiomas that are deep [10] ."}
{"id": "article-22692_11", "title": "Hemangioma -- Differential Diagnosis", "content": "When considering hemangiomas, there are various differentials that fall into this category. It is important to consider each of them to obtain the accurate diagnosis. Congenital hemangioma Pyogenic granuloma Kaposiform hemangioendothelioma Tufted hemangioma Venous malformation Capillary malformation: port wine stain Macrocystic lymphatic malformation Malignant tumors: sarcoma, a cutaneous location of neuroblastoma\u00a0or lymphoma", "contents": "Hemangioma -- Differential Diagnosis. When considering hemangiomas, there are various differentials that fall into this category. It is important to consider each of them to obtain the accurate diagnosis. Congenital hemangioma Pyogenic granuloma Kaposiform hemangioendothelioma Tufted hemangioma Venous malformation Capillary malformation: port wine stain Macrocystic lymphatic malformation Malignant tumors: sarcoma, a cutaneous location of neuroblastoma\u00a0or lymphoma"}
{"id": "article-22692_12", "title": "Hemangioma -- Prognosis", "content": "The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention.", "contents": "Hemangioma -- Prognosis. The prognosis is very good for uncomplicated IH and there is complete involution in the majority of cases. 50% of hemangiomas will resolve in 5 years, 70% by 7 years and 90% by 9 years. Approximately 8% of IH leave cosmetic disfigurement and require some intervention."}
{"id": "article-22692_13", "title": "Hemangioma -- Complications", "content": "The complications depend on the patient's age and on the\u00a0hemangioma's size and location. The complications of IH are listed below.", "contents": "Hemangioma -- Complications. The complications depend on the patient's age and on the\u00a0hemangioma's size and location. The complications of IH are listed below."}
{"id": "article-22692_14", "title": "Hemangioma -- Complications", "content": "Ulceration is the most common complication and occurs in up to 10% of cases. Locations with higher risk of ulceration include the anogenital area, lower lip, axilla, and neck.", "contents": "Hemangioma -- Complications. Ulceration is the most common complication and occurs in up to 10% of cases. Locations with higher risk of ulceration include the anogenital area, lower lip, axilla, and neck."}
{"id": "article-22692_15", "title": "Hemangioma -- Complications", "content": "Ophthalmologic complications include amblyopia, astigmatism, myopia, retrobulbar involvement and tear duct obstruction.", "contents": "Hemangioma -- Complications. Ophthalmologic complications include amblyopia, astigmatism, myopia, retrobulbar involvement and tear duct obstruction."}
{"id": "article-22692_16", "title": "Hemangioma -- Complications", "content": "Airway obstruction can be\u00a0seen in nasal, subglottic and laryngeal passages.", "contents": "Hemangioma -- Complications. Airway obstruction can be\u00a0seen in nasal, subglottic and laryngeal passages."}
{"id": "article-22692_17", "title": "Hemangioma -- Complications", "content": "Difficulties feeding can be seen with perioral or lip hemangiomas.", "contents": "Hemangioma -- Complications. Difficulties feeding can be seen with perioral or lip hemangiomas."}
{"id": "article-22692_18", "title": "Hemangioma -- Complications", "content": "Visceral hemangiomatosis, especially multifocal hemangiomas (greater than or equal to\u00a05 skin lesions), may be associated with liver or gastrointestinal involvement.", "contents": "Hemangioma -- Complications. Visceral hemangiomatosis, especially multifocal hemangiomas (greater than or equal to\u00a05 skin lesions), may be associated with liver or gastrointestinal involvement."}
{"id": "article-22692_19", "title": "Hemangioma -- Complications", "content": "Cosmetic disfigurement can be seen\u00a0with large facial area involvement or involvement of\u00a0the nasal tip (called Cyrano nose), ears and perioral area.", "contents": "Hemangioma -- Complications. Cosmetic disfigurement can be seen\u00a0with large facial area involvement or involvement of\u00a0the nasal tip (called Cyrano nose), ears and perioral area."}
{"id": "article-22692_20", "title": "Hemangioma -- Complications", "content": "PHACES syndrome\u00a0manifests with a large segmental facial hemangioma (greater than or equal to 5 cm). The PHACES syndrome\u00a0acronym stands for posterior fossa malformations, hemangioma of the cervicofacial region, arterial anomalies, cardiac anomalies, eye anomalies, and Sternal or abdominal clefting [3] .", "contents": "Hemangioma -- Complications. PHACES syndrome\u00a0manifests with a large segmental facial hemangioma (greater than or equal to 5 cm). The PHACES syndrome\u00a0acronym stands for posterior fossa malformations, hemangioma of the cervicofacial region, arterial anomalies, cardiac anomalies, eye anomalies, and Sternal or abdominal clefting [3] ."}
{"id": "article-22692_21", "title": "Hemangioma -- Complications", "content": "LUMBAR syndrome\u00a0manifests with lumbosacral hemangiomas and may be associated with underlying developmental anomalies. The LUMBAR syndrome acronym represents lumbosacral hemangioma, urogenital anomalies, myelopathy, bony deformities, anorectal\u00a0or arterial, and renal anomalies [3]", "contents": "Hemangioma -- Complications. LUMBAR syndrome\u00a0manifests with lumbosacral hemangiomas and may be associated with underlying developmental anomalies. The LUMBAR syndrome acronym represents lumbosacral hemangioma, urogenital anomalies, myelopathy, bony deformities, anorectal\u00a0or arterial, and renal anomalies [3]"}
{"id": "article-22692_22", "title": "Hemangioma -- Enhancing Healthcare Team Outcomes", "content": "The goal in identifying hemangiomas and treating them is to prevent their complications. One of the most serious complications includes\u00a0permanent cosmetic disfigurement that may have a psychosocial impact on the patient and the family. The management of IH is best done with an interprofessional approach. This would consist of a team with pediatricians, dermatologists, ophthalmologists, and other specialists.", "contents": "Hemangioma -- Enhancing Healthcare Team Outcomes. The goal in identifying hemangiomas and treating them is to prevent their complications. One of the most serious complications includes\u00a0permanent cosmetic disfigurement that may have a psychosocial impact on the patient and the family. The management of IH is best done with an interprofessional approach. This would consist of a team with pediatricians, dermatologists, ophthalmologists, and other specialists."}
{"id": "article-22692_23", "title": "Hemangioma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Hemangioma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}